334 related articles for article (PubMed ID: 16042416)
21. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
[TBL] [Abstract][Full Text] [Related]
22. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
23. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
24. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
25. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
[TBL] [Abstract][Full Text] [Related]
26. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
27. Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
El Dirani-Diab R; Sarih-Cottin L; Delord B; Dumon B; Moreau S; Toulme JJ; Fleury H; Litvak S
Antimicrob Agents Chemother; 1997 Oct; 41(10):2141-8. PubMed ID: 9333039
[TBL] [Abstract][Full Text] [Related]
28. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase.
Yanagita H; Urano E; Matsumoto K; Ichikawa R; Takaesu Y; Ogata M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
Bioorg Med Chem; 2011 Jan; 19(2):816-25. PubMed ID: 21193314
[TBL] [Abstract][Full Text] [Related]
29. 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
Tang J; Liu F; Nagy E; Miller L; Kirby KA; Wilson DJ; Wu B; Sarafianos SG; Parniak MA; Wang Z
J Med Chem; 2016 Mar; 59(6):2648-59. PubMed ID: 26927866
[TBL] [Abstract][Full Text] [Related]
30. Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture.
Archer RH; Dykes C; Gerondelis P; Lloyd A; Fay P; Reichman RC; Bambara RA; Demeter LM
J Virol; 2000 Sep; 74(18):8390-401. PubMed ID: 10954539
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives.
Tatyana K; Francesca E; Luca Z; Giovanni F; Cheng YC; Ginger ED; Enzo T
Med Chem; 2009 Sep; 5(5):398-410. PubMed ID: 19534674
[TBL] [Abstract][Full Text] [Related]
32. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.
Tang J; Kirby KA; Huber AD; Casey MC; Ji J; Wilson DJ; Sarafianos SG; Wang Z
Eur J Med Chem; 2017 Mar; 128():168-179. PubMed ID: 28182989
[TBL] [Abstract][Full Text] [Related]
33. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
Gao HQ; Boyer PL; Arnold E; Hughes SH
J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880
[TBL] [Abstract][Full Text] [Related]
34. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
[TBL] [Abstract][Full Text] [Related]
35. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
Boso G; Örvell C; Somia NV
J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
[TBL] [Abstract][Full Text] [Related]
36. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
[TBL] [Abstract][Full Text] [Related]
37. Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT.
Métifiot M; Leon O; Tarrago-Litvak L; Litvak S; Andréola ML
Biochimie; 2005; 87(9-10):911-9. PubMed ID: 16164998
[TBL] [Abstract][Full Text] [Related]
38. Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication.
Esposito F; Carli I; Del Vecchio C; Xu L; Corona A; Grandi N; Piano D; Maccioni E; Distinto S; Parolin C; Tramontano E
Phytomedicine; 2016 Nov; 23(12):1383-1391. PubMed ID: 27765358
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 integrase and RNase H activities as therapeutic targets.
Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
[TBL] [Abstract][Full Text] [Related]
40. 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.
Corona A; Onnis V; Del Vecchio C; Esposito F; Cheng YC; Tramontano E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
